首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods
【24h】

Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods

机译:含有共 - 非晶态盐的多组分片剂的制备与表征:与建立的分析方法相结合多峰非线性光学成像

获取原文
获取原文并翻译 | 示例
       

摘要

Co-amorphous mixtures have rarely been formulated as oral dosage forms, even though they have been shown to stabilize amorphous drugs in the solid state and enhance the dissolution properties of poorly soluble drugs.In the present study we formulated tablets consisting of either spray dried co-amorphous ibuprofen-arginine or indomethacin-arginine, mannitol or xylitol and polyvinylpyrrolidone K30 (PVP). Experimental design was used for the selection of tablet compositions, and the effect of tablet composition on tablet characteristics was modelled. Multimodal non-linear imaging, including coherent anti-Stokes Raman scattering (CARS) and sum frequency/second harmonic generation (SFG/SHG) microscopies, as well as scanning electron microscopy, X-ray diffractometry and Fourier-transform infrared spectroscopy were utilized to characterize the tablets.The tablets possessed sufficient strength, but modelling produced no clear evidence about the compaction characteristics of co-amorphous salts. However, co-amorphous drug-arginine mixtures resulted in enhanced dissolution behaviour, and the PVP in the tableting mixture stabilized the supersaturation. The co-amorphous mixtures were physically stable during compaction, but the excipient selection affected the long term stability of the ibuprofen-arginine mixture. CARS and SFG/SHG proved feasible techniques in imaging the component distribution on the tablet surfaces, but possibly due to the limited imaging area, recrystallization detected with x-ray diffraction was not detected.
机译:共聚的混合物很少被配制为口服剂型,即使它们已被证明稳定在固态中的无定形药物,并增强可溶于可溶性药物的溶解性能。本研究我们配制了由喷雾干燥的CO组成的片剂 - 阿甲醛布洛芬 - 精氨酸或吲哚美辛 - 精氨酸,甘露醇或木糖醇和聚乙烯吡咯烷酮K30(PVP)。实验设计用于选择片剂组合物,平板电脑组合物对片剂特征的影响是模拟的。多模式非线性成像,包括相干的防斯托克斯拉曼散射(汽车)和和频率/二次谐波产生(SFG / SHG)显微镜,以及扫描电子显微镜,X射线衍射测定和傅立叶变换红外光谱分析表征片剂。片剂具有足够的强度,但是模型没有关于共聚盐的压实特性的明确证据。然而,共 - 无定形药物 - 精氨酸混合物导致增强的溶解行为,并且压片混合物中的PVP稳定过饱和度。在压实过程中,共聚混合物在物理上稳定,但赋形剂选择影响了布洛芬 - 精氨酸混合物的长期稳定性。汽车和SFG / SHG证明了可行的技术在将组件分布上成像在片状表面上,但可能由于有限的成像区域,未检测到用X射线衍射检测的重结晶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号